Buaya, Stephanie Jane A.

HRN: 05-24-32  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2023
CEFTRIAXONE 1G (VIAL)
07/16/2023
07/22/2023
IVT
2g
OD
Calculous Cholecystitis
Waiting Final Action 
07/16/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/16/2023
07/22/2023
IVT
500mg
Q8
Calculous Cholecystitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: